Antimicrobial and antiquorum-sensing studies. Part 3: Synthesis and biological evaluation of new series of [1,3,4]thiadiazoles and fused [1,3,4]thiadiazoles

Archiv der Pharmazie
Nadia S El-Gohary, Mona I A Shaaban

Abstract

New series of [1,3,4]thiadiazoles and fused [1,3,4]thiadiazoles were synthesized. The newly synthesized compounds were screened for their antibacterial activity against Staphylococcus aureus, Bacillus cereus, and Escherichia coli. Compounds 3b and 10a displayed the highest activity against E. coli with MIC value of 78.125 μg/mL. In addition, compound 10a exhibited the highest activity against B. cereus with MIC value of 156.25 μg/mL. The antifungal activity of these compounds was also tested against Candida albicans and Aspergillus flavus 3375. Compounds 3b, 5a, 10a, and 12b showed the best activity against A. flavus 3375 with MIC value of 19.531 μg/mL. The same compounds were examined for their antiquorum-sensing activity against Chromobacterium violaceum ATCC 12472, whereas compounds 3b, 5a, and 12b exhibited moderate activity. In vitro cytotoxicity testing of compounds 3b,c, 5a, 6a, 10a, and 12a,b against human normal lung fibroblast (W138) cell line was performed. The in vivo acute toxicity of the same compounds was also tested and the obtained results indicated that compound 10a is the least toxic analog. The same compounds were studied for their DNA-binding affinity and the obtained results showed that compounds 3b, 10a, ...Continue Reading

References

Oct 1, 1975·Journal of Clinical Pathology·R J Holt
Nov 20, 1986·Journal of Immunological Methods·D Gerlier, N Thomasset
Jan 19, 1999·Annual Review of Microbiology·J A Shapiro
Jun 23, 2001·The Journal of Antimicrobial Chemotherapy·J M Andrews
Sep 7, 2001·Annual Review of Microbiology·M B Miller, B L Bassler
Jan 30, 2002·The Journal of Antimicrobial Chemotherapy·Pei-Ching Shih, Ching-Tsan Huang
May 31, 2002·Journal of Medicinal Chemistry·Daniel F VeberKenneth D Kopple
Mar 26, 2003·Infection and Immunity·Justin MerrittWenyuan Shi
Jul 26, 2003·The EMBO Journal·Morten HentzerMichael Givskov
Feb 1, 1958·The Journal of Pharmacy and Pharmacology·V PETROWA M WILD
Nov 5, 2003·The Journal of Clinical Investigation·Michael J Federle, Bonnie L Bassler
Jan 11, 2005·Trends in Microbiology·Matthew R Parsek, E P Greenberg
May 3, 2005·Leukemia Research·M TsurusawaUNKNOWN MDS committee of the Japanese Society of Pediatric Hematology
Oct 11, 2005·Annual Review of Cell and Developmental Biology·Christopher M Waters, Bonnie L Bassler
Sep 7, 2007·Environmental Microbiology·Julien TremblayEric Déziel
May 6, 2008·Journal of Bacteriology·Susanne B von BodmanStephen P Diggle
Mar 4, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jenny Fernebro
Jun 28, 2011·European Journal of Medicinal Chemistry·Nadia S El-SayedMohammed M El-Kerdawy
Jun 30, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kamal F M AttaMohamed G Marei
Oct 13, 2011·MBio·Brett Mellbye, Martin Schuster
Nov 29, 2011·European Journal of Medicinal Chemistry·Azza T TaherHussein I El-Subbagh
Mar 12, 2013·European Journal of Medicinal Chemistry·Nadia S El-Gohary, Mona I Shaaban
Jun 3, 2014·Marine Drugs·Kaihao Tang, Xiao-Hua Zhang

❮ Previous
Next ❯

Citations

Nov 23, 2019·Mini Reviews in Medicinal Chemistry·Mahesh S VasavaHitesh D Patel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.